Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (241-250 of 346) with videos related to

Pageof 35
Sort By:
Blood Advances|February 22, 2024
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemiaRegina M Myers, Kaitlin Devine, Yimei Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
Impact of Risk-Stratified Therapy on Health Status in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
JAMA Oncology|January 27, 2022
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Federico Antillon-Klussmann, Deqing Pei, et al.
The Lancet. Haematology|July 5, 2023
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trialStephen P Hunger, Thai Hoa Tran, Vaskar Saha, et al.
Nature Communications|July 8, 2025
Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndromeZhenhua Li, Wenjian Yang, Gang Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932Anne L Angiolillo, Reuven J Schore, John A Kairalla, et al.
Blood|November 3, 2009
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaHuining Kang, I-Ming Chen, Carla S Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
JAK mutations in high-risk childhood acute lymphoblastic leukemiaCharles G Mullighan, Jinghui Zhang, Richard C Harvey, et al.
Pageof 35

Showing results (241-250 of 346) with videos related to

Sort By:
Pageof 35
Blood Advances|February 22, 2024
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemiaRegina M Myers, Kaitlin Devine, Yimei Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
Impact of Risk-Stratified Therapy on Health Status in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
JAMA Oncology|January 27, 2022
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Federico Antillon-Klussmann, Deqing Pei, et al.
The Lancet. Haematology|July 5, 2023
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trialStephen P Hunger, Thai Hoa Tran, Vaskar Saha, et al.
Nature Communications|July 8, 2025
Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndromeZhenhua Li, Wenjian Yang, Gang Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932Anne L Angiolillo, Reuven J Schore, John A Kairalla, et al.
Blood|November 3, 2009
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaHuining Kang, I-Ming Chen, Carla S Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
JAK mutations in high-risk childhood acute lymphoblastic leukemiaCharles G Mullighan, Jinghui Zhang, Richard C Harvey, et al.
Pageof 35